Leidos (NYSE: LDOS), a health, national security, and engineering solutions company, was awarded a prime contract by the U.S. Army to provide medical product and research development to the U.S. Army Medical Research and Materiel Command (USAMRMC). The multiple-award indefinite-delivery/indefinite-quantity contract has a five-year base period of performance, five-one year options, and a total contract value of $900 million for all awardees, if all options are exercised. Leidos is one of four contractors eligible to compete for task orders under the contract. Work will be performed primarily in Frederick, Md.

The USAMRMC develops, acquires, provides, and sustains world-class solutions and capabilities to enable medical readiness globally. Under the contract, Leidos Life Sciences will provide medical product research and development services to support the missions of the U.S. Army Medical Materiel Development Activity, U.S. Army Medical Materiel Agency, other subordinate commands of the U.S. Army Medical Research and Materiel Command, Joint Project Manager Medical Countermeasure Systems, and other Department of Defense (DoD) entities responsible for medical product research and development. Work under the contract is intended to support the entire scope of developing new drugs, vaccines, blood products, medical devices, and medical support equipment that enhances readiness, ensures the provision of the highest quality medical and preventive care to the DoD, and maximizes survival of medical casualties on the battlefield.

"Our Life Sciences team located in Frederick, Maryland, led by Dr. Jim Pannucci, has proudly supported the U.S. Army Medical Research and Material Command for more than 33 years," said Jerry Hogge, deputy group president of Leidos Federal Health. "Our distinguished scientists and researchers look forward to providing research and development for medical products to deliver solutions that can help save and improve the lives of our military service members."

About Leidos

Leidos is a science and technology solutions leader working to address some of the world's toughest challenges in national security, health and engineering. The Company's 19,000 employees support vital missions for government and the commercial sector, develop innovative solutions to drive better outcomes and defend our digital and physical infrastructure from 'new world' threats. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $5.06 billion for its fiscal year ended January 30, 2015. For more information, visit www.Leidos.com. 

There are many enjoyable life experiences that accompany motherhood, but back pain isn't one of them. Instead, this is a common complaint of new mothers due to the added task of lifting and carrying an infant or toddler on a daily basis.

The American Academy of Orthopaedic Surgeons (AAOS) encourages mothers to be aware of back pain and consider safety tips which can help to reduce the risks of this condition.  

EXPERT ADVICE

"Back pain presents a problem to many mothers caring for their babies," said orthopaedic surgeon and AAOS spokesperson Sabrina Strickland, MD. "Initially, mothers may start off lifting their child of seven to 10 pounds, numerous times per day. Slowly the weight load increases as the child grows, and if the proper lifting techniques aren't used, this can lead to back strain."

AAOS BACK PAIN PREVENTION TIPS

Ten ways that new mothers can help to reduce their risk of injury and back pain. Many of these tips also work well with new fathers:

•     Once cleared by your doctor, begin exercising soon after delivery to restore muscle tone to the abdominal and back muscles. While the baby is napping, take 10 minutes to do stretching and strengthening exercises on the floor each day. This will help restore hip and back flexibility and strength.
•     Try to return to your normal weight within six months after giving birth, but start eating a healthy diet immediately.
•     Do not lift the baby with outstretched arms. Instead bring the baby close to your chest and then lift. Avoid twisting your body.
•     To pick up a child from the floor, bend at your knees, not at your waist. Squat down, tighten your stomach muscles and lift with your legs.
•     Remove the high chair tray when you are trying to put the baby in or take the baby out of the high chair.
•     When lifting a baby out of the crib, bringing the child close to you while slightly bending your knees can reduce back strain. When getting a new crib, remember choosing one that is appropriately sized for your height will make lifting your infant easier.
•     Consider using a "front pack" to carry the baby when you are walking.
•     Do not carry a child on your hip; this overloads the back muscles and if you must, alternate sides.
•     To avoid upper back pain from nursing, bring the baby to your breast, rather than bending over the baby. While you are nursing, use a pillow or a specially designed nursing pillow to elevate the baby.
•     Do not stand outside the car to place the child in the car seat. Instead, place one foot in the car on the floor as you place the baby into the car seat. When purchasing a car, remember that a four-door vehicle will make it easier to place the child in a car seat.

Note: If you had a Caesarian-section (C-section) delivery, wait until you get the permission of your obstetrician before you begin exercising.

More tips:

Preventing back pain in new moms orthopaedic surgeons restore mobility and reduce pain; they help people get back to work and to independent, productive lives. Visit ANationInMotion.org to read successful orthopaedic stories.  

Newsroom.aaos.org is your source for bone and joint health news, stats, facts, images and spokesperson interview requests.

Visit us:

Orthoinfo.org
About the American Academy of Orthopaedic Surgeons
Facebook.org/AAOS1
Twitter.com/AAOS1
Plus.Google.com/+AAOSPR

MEMPHIS, Tenn., Aug. 17, 2015 /PRNewswire-USNewswire/ — St. Jude Children's Research Hospital has named Keith Perry as chief information officer (CIO) to provide strategic counsel and leadership for the hospital's information technology initiatives.  

Keith Perry, CIO, St. Jude Children's Research Hospital

"Our internal IT systems and operations play a critical role in the success of our institution," said James R. Downing, M.D., St. Jude president and chief executive officer. "Keith's extensive knowledge will support the utilization of new technologies and advancements to provide the highest quality of care for our patients and families."

Perry joins St. Jude from the University of Texas MD Anderson Cancer Center in Houston where he served as associate vice president and deputy chief information officer. Some of his greatest accomplishments in this role include; managing the division's 290 million dollar annual budget, and implementing high performance computing programs to support research and clinical applications, such as next-generation genomic sequencing and proton beam modeling.

"Today, more than ever, technology plays a large role in patient care and a hospital's organization," said Perry. "I look forward to being part of the St. Jude team and contributing to the hospital's mission of finding cures and saving children."

Perry earned a bachelor's degree in computer science from Harding University in Searcy, Arkansas, and an MBA from the University of Houston.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food—because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. jude at @stjuderesearch.

Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced today that it will report financial results for the fourth quarter and fiscal year 2015 on Thursday, August 20, 2015. The company has scheduled a conference call that same day, Thursday, August 20, 2015, at 4:30 pm ET to review the results.

Interested parties can access the conference call by dialing (877) 317-6789 or (412) 317-6789 or can listen via a live Internet webcast, which is available in the Investor Relations section of the Company's website at www.misonix.com.  

A teleconference replay of the call will be available for three days at (877) 344-7529 or (412) 317-0088, confirmation # 10071256. A webcast replay will be available in the Investor Relations section of the Company's website at www.misonix.com for 30 days.

About Misonix

Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several
innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.

Safe Harbor Statement

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

Company Contact:
   
Investor Contacts:

Richard Zaremba
Robert Blum, Joe Dorame, Joe Diaz
Misonix, Inc.
Lytham Partners, LLC       
631-694-9555
602-889-9700
invest@misonix.com
mson@lythampartners.com
www.misonix.com
www.lythampartners.com

More than 5,400 association professionals and industry partners attended the 2015 ASAE Annual Meeting & Exposition, August 8-11, in Detroit. Attendees participated in more than 130 education sessions, networked in the exhibit hall, and took part in Detroit Destination Tours and EduTours. The ASAE Foundation sold more than 2,000 tickets to The Classic, held at Detroit's Fox Theatre, which is the highest attendance in its history.

The final attendance breakdown includes: 2,812 executives, 1,799 exhibitors, 790 others, including guests, spouses, press, volunteers, vendors, and staff, for a grand total of 5,401.

A total of 431 companies representing 684 booths exhibited in the expo hall this year, which resulted in a strong ratio of 61 percent buyers (association staff) to 39 percent sellers (industry partners).

"Eighty-seven percent of attendees had not held a meeting in Detroit in the last 15 years, so this provided Detroit Metro CVB a great opportunity to reveal the newly renovated cobo Center and different meeting locations throughout the city," said ASAE President & CEO John H. Graham IV, FASAE, CAE. "Attendees were buzzing about Cobo, the wonderful hospitality, and great content at this year's event."

During the Opening General Session on August 9, Josh Linkner, CEO and managing partner of Detroit Venture Partners, provided five "obsessions" of innovative thinkers as well as strategies attendees can use back in the office. He discussed the importance of being curious, craving what's next, doing a "judo flip," finding solutions in unorthodox ways, and pushing the boundaries.

During the Closing General Session on August 11, Sherry Turkle, an MIT professor and author, outlined how technology is impacting our conversations and creating a crisis in empathy that can be cured with having face-to-face conversations. She encouraged attendees to create device-free time and space, unitask instead of multitask, and use the seven-minute rule in conversations.

ASAE held three sold out workshops during the Annual Meeting & Exposition: the Aspiring CEO Deep Dive, Achieving Global Growth, and Executive Leadership Program.

For more information, please visit ASAE's Annual Meeting & Exposition website.

ASAE raised $35,000 for Alternative For Girls, which helps homeless and high-risk girls and young women avoid violence, teen pregnancy, and exploitation. Participants made bookmarks, read to the girls, and packed hygiene kits. ASAE raised money through volunteer efforts, city tours, 5K Fun Run/Walk fees, and individual donations.

The 2016 ASAE Annual Meeting & Exposition will be in Salt Lake City, Utah on August 13–16.

ASAE thanks the following Alliance Partners for their continued support of the association community:

Strategic Partners
Abila
Aptify
Atlanta CVB
Business Events Canada
Detroit Metro CVB
Personify
Reno Tahoe USA
Team San Jose
Corporate Partners
Visit Baltimore
Dallas CVB
Greater Fort Lauderdale CVB
Fort Worth CVB
GEICO
Louisville CVB
Mexico Tourism Board
Naylor Association Solutions
Omaha CVB
Visit Orlando
Visit Salt Lake
Meet in Washington State
Event Partners
BrightKey
The Broadmoor
CliftonLarsonAllen
DelCor Technology Solutions
Dubai Association Centre
Hong Kong Tourism Board
Johnson Lambert LLP and Veris Consulting Inc.
Korea Tourism Organization
Manifest
MemberClicks
Meet In Minnesota
New Orleans CVB and New Orleans Ernest N. Morial Convention Center

 

About ASAE: The Center for Association Leadership ASAE is a membership organization of more than 21,000 association executives and industry partners representing 9,300 organizations. Its members manage leading trade associations, individual membership societies and voluntary organizations across the united States and in nearly 50 countries around the world. With support of the ASAE Foundation, a separate nonprofit entity, ASAE is the premier source of learning,

knowledge and future-oriented research for the association and nonprofit profession, and provides resources, education, ideas and advocacy to enhance the power and performance of the association and nonprofit community. For more information about ASAE, visit www.asaecenter.org.

Dr. Anne L. White of Carolina Laser and Cosmetic Center (www.CarolinaLaser.com) is the only practice in the Triad area to offer this unprecedented innovation in laser technology–The New Vectus® Laser for hair removal.

The Cynosure® Vectus Laser is the intelligent choice for the fastest laser hair removal available. With the proven reliability, the Vectus Laser provides high-volume permanent hair reduction for a wide range of skin and hair types – without sacrificing client comfort.

Featuring the largest spot size and most uniform beam profile available today, the Vectus laser allows for quick treatment of unwanted hair, even in the largest areas, such as the back, in less than five minutes.

The advantages of laser hair removal with the Vectus® Laser include:  excellent, long-term results, fast treatment sessions that can take only minutes, great for reducing hair from larger areas and, comfortable treatments with no downtime. You can resume regular daily activities immediately following treatment.

Dr. White says she's excited to be able to add this advanced technology to the wide array of non-surgical, no downtime and minimal downtime procedures she currently offers.

She has been providing successful laser hair removal treatments to patients since 2002.

"With the Vectus® Laser added, we're taking a huge leap forward in accommodating patient requests for more efficient and comfortable removal with no downtime which is a huge benefit to them."

"At Carolina Laser and Cosmetic Center we are passionately committed to providing the safest and latest non-surgical, non-invasive, no downtime cosmetic, laser and dermatology treatments to help patients look as young outside as they feel inside," Dr. white says.

Anne L. White, M.D. has been in private practice in Winston-Salem since 1988 and has focused on cosmetic and laser procedures since 2002. She is a Winston-Salem Cosmetic Surgeon and medical Director of Carolina Laser and Cosmetic Center. She is known to be the first in offering the latest, safest and effective products and procedures to the Winston-Salem, Greensboro and High Point Triad. She is well-gifted and her patients often remark she has an artistic eye and a gentle touch. She is a fellow of the American Academy of Cosmetic Surgery, American Society for Lasers in Medicine and Surgery, and the American College of Phlebology.

Levi & Korsinsky announces it has commenced an investigation of Ariad Pharmaceuticals Inc. (NasdaqGS: ARIA) concerning possible breaches of fiduciary duty by its Board of Directors. To obtain additional information, GO TO:http://zlk.9nl.com/ariadpharmaceuticals or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Protecting the Rights of Shareholders.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street – 24th FloorNew York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its first quarter ended June 30, 2016 of Fiscal Year 2016.

Revenues for the three months ended June 30, 2015 were $1,055,928 as compared to $623,674 for the three months ended June 30, 2014, an increase of 69%.  Net profit for the first quarter was $434,548 or $0.01 per share as compared to $35,828 for the same period last year, an increase of 1,113%.  Complete financial results are available in the company's Quarterly Report on Form 10Q available at www.sec.gov.

As previously announced, on August 7, 2015 ADMT secured a strategic investment of $300,000 from its customer Advanced Plasma Therapies, Inc. ("APT") and issued 2,068,965 shares of ADMT's common stock to APT, such shares are restricted securities and have not been registered for public sale.   The strategic investment occurred after the end of the June 30, 2015 first fiscal quarter.  Therefore, the share amounts reflected above do not include the shares issued to APT.

"We are continuing the positive strides achieved over the past fiscal year into this new fiscal year," stated Andre' DiMino, President of ADMT.  Our positive financial results are fueling our growth with positive cash flow from our operations.  We expect continued growth in our medical device engineering segment.  And, with the added capital from operations, as well as the recent strategic investment received from APT, we plan to advance our proprietary medical device projects as well."

About ADMT

ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products.  Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house.  ADMT has three areas of activity: Proprietary Electronic Medical Devices; Eco-Friendly, Safe, Water-Based Formulations; and, Design, Engineering, Regulatory and Manufacturing Services.  The Company's headquarters, laboratories, FDA-Registered medical device and manufacturing operations are located in Northvale, NJ.  ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D solid prototyping, precision instrumentation and specialized software and peripherals, for the research, development and commercialization of diversified technologies. Additional information is available at the Company's websites – admtronics.com and concepttoquantity.com .